Actual Medicinal Product (AMP) - Recivit 133microgram sublingual tablets (Grunenthal Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Current Name | Recivit 133microgram sublingual tablets | 14-04-2014 | |
Summary
- Discontinued
- Controlled Drug Category
- Schedule 2 (CD)
- Licensed Route
- Sublingual
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 04070200 | Start Date 29-08-2014 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 24406811000001106 | 14-04-2014 |
Parent Products
-
VTMFentanyl
-
VMPFentanyl 133microgram sublingual tablets sugar ...
-
AMP(Current) Recivit 133microgram sublingua... (Other AMPs)
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 30 tablet |